Published by Coherent Market Insights
Posted on September 21, 2021
5 min readLast updated: February 4, 2026
The non-invasive hemodynamic monitoring market is set to grow at a 7.0% CAGR from 2021 to 2027, driven by rising heart disease prevalence and technological advancements.
Constant blood pressure monitoring is one of the quintessential steps taken to avoid hypoperfusion and also guide fluid administration. Blood pressure (noninvasive) can be obtained continuously using the finger cuff technology and the cardiac output is effortlessly achieved using the pulse contour method. Hemodynamic monitoring is the measurement of blood pressure inside the heart, veins, and arteries. Moreover, it measures blood flow and how much oxygen is in the blood. It also finds application to observe how well the heart is working. For nonstop measurement of blood pressure, cannulation of the artery affected is the basic approach. However, continuous and noninvasive monitoring of BP has many advantages, mainly if the intra-arterial measurement of blood pressure is not warranted whilst intermittent measurement does not have required time resolution. The finger cuff technology is capable of offering such noninvasive and continuous monitoring of BP as well as other hemodynamics parameters. Owing to these factors, the global non-invasive hemodynamic monitoring system market is expected to experience a steady growth during the forecast period.
Hemodynamic monitoring systems are primarily used for medical inspection of cardiovascular health, quality and longevity of life of patients undergoing as well as recovering from cardiac surgery. The aforementioned parameters are typically measured by using photometric, electrical, pressure transducing equipment and invasive as well as noninvasive devices. Hemodynamic monitoring systems use various intravascular catheters as well. Some of the factors boosting the demand for non-invasive hemodynamic monitoring systems are rising incidences of respiratory disorders, growing occurrence of lifestyle diseases, increasing demand for screening of CCHD or critical congenital heart disease, private as well as government initiatives to decrease healthcare costs and increasing geriatric population across the world.
Request for Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/405
Global Non-invasive hemodynamic monitoring system market taxonomy
On the basis of application, the market is classified into:
On the basis of end-user, the market is classified into:
Market Dynamics- Driver
Increasing prevalence of heart diseases will drive the global non-invasive hemodynamic monitoring system market growth
Growing prevalence of heart disease is expected to drive growth of the global non-invasive hemodynamic monitoring system market during the forecast period. According to Center for Disease Control and Prevention, in 2015, around 28.4 million people were diagnosed with heart diseases in the U.S. alone, i.e., around 11.7% of the population. This number is expected to increase in the near future, owing to changes in lifestyle and food habits. Since heart diseases require constant monitoring of hemodynamic, which in turn, is expected to drive the market growth in the near future.
Regional Insights
Among regions, North America holds the dominant position in the global non-invasive hemodynamic monitoring system market, owing to technological advancements and initiatives are being adopted by market players in the region. Moreover, rising usage of heart patient monitoring systems in Canada, high diabetes prevalence are expected to drive the North America non-invasive hemodynamic monitoring system market growth over the forecast period. Furthermore, Asia Pacific is expected to account for the second-largest share of the market, with China, Japan, and India positioned as growth engines. Emerging economies such as India and China are expected to witness high growth for non-invasive hemodynamic monitoring system. According to American Diabetic Association, around 60% of the world’s diabetic population lives in Asia. The prevalence of diabetes in India and China is 8.6% and 9.6% respectively. India is known as the diabetes capital of the world with more than 60 million diabetics in the country as of 2014. Factors such as aging population in and high prevalence of diabetes in, increasing prevalence of cardiac diseases, and increase in healthcare spending by the population in emerging economies such as India, China, and Brazil, are driving the growth of the market in these regions.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/405
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Competitive Landscape
Major companies operating in the global non-invasive hemodynamic monitoring system market are Pulsion Medical Systems SE, Edwards Lifesciences Corporation, and LiDCO Group plc. These companies together contributed to about more than half of the market in 2016. The other players of the market are Deltex Medical Group Plc., Cheetah Medical Inc., ICU Medical, Inc., Hemo Sapiens, In., Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical, Inc.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Non-Invasive Hemodynamic Monitoring System Market expected to witness a CAGR of 7.0% during the forecast period 2021-2027| Coherent Market Insights appeared first on Gatorledger.
The article discusses the growth of the non-invasive hemodynamic monitoring system market from 2021 to 2027.
Market growth is driven by the rising prevalence of heart diseases and technological advancements.
North America leads due to technological advancements, while Asia Pacific shows high growth potential.
Explore more articles in the Research Reports category
